Lipid peroxides in stable asthmatics receiving inhaled steroids and long-acting β2-agonists

Respirology

Volumn 12, Issue 3, 2007, Pages 439-442

  Alzoghaibi, Mohammed A ^a   BaHammam, Ahmed S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Asthma; Lipid peroxide; Malondialdehyde; Oxidative stress; Steroid; Thiobarbituric acid

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; LIPID PEROXIDE; LONG ACTING DRUG; SALBUTAMOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ANDROSTANE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; DRUG DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUTICASONE; FORMOTEROL; REACTIVE OXYGEN METABOLITE; SALMETEROL;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SYMPTOMATOLOGY; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ANDROSTADIENES; ASTHMA; BUDESONIDE; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; HUMANS; LIPID PEROXIDES; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 34547409883     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01034.x     Document Type: Article

References (21)

1. Chanez P, Dent G, Yukawa T, Barnes PJ, Chung KF. Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester. Eur. Respir. J. 1990 3 : 1002 7.
2. Cotran RS, Kumar V, Collins T, Robbins SL. Robbins Pathologic Basis of Disease. W.B. Saunders Company, Philadelphia, PA, 1999.
3. Porth C. Pathophysiology: Concepts of Altered Health States. J.B. Lippincott Co, New York, 1990.
4. Cluzel M, Damon M, Chanez P, Bousquet J, Crastes de Paulet A, et al. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J. Allergy Clin. Immunol. 1987 80 : 195 201.
5. Vachier I, Damon M, Le Doucen C, de Paulet AC, Chanez P, et al. Increased oxygen species generation in blood monocytes of asthmatic patients. Am. Rev. Respir. Dis. 1992 146 : 1161 6.
6. Rice-Evans C, Burdon R. Free radical-lipid interactions and their pathological consequences. Prog. Lipid. Res. 1993 32 : 71 110.
7. Barnes BJ. Reactive oxygen species and airway inflammation. Free Radic. Biol. Med. 1990 9 : 235 43.
8. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am. J. Respir. Crit. Care Med. 1996 154 : 1055 60.
9. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000 35 : 967 74.
10. Kelly FJ, Mudway I, Blomberg A, Frew A, Sandstrom T. Altered lung antioxidant status in patients with mild asthma. Lancet 1999 354 : 482 3.
11. Walsh SW. Lipid peroxidation in pregnancy. Hypertens. Pregnancy 1994 13 : 1 32.
12. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence. Lancet 1994 344 : 721 4.
13. Roberts JA, Bradding P, Britten KM, Walls AF, Wilson S, et al. The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur. Respir. J. 1999 14 : 275 82.
14. Leru P, Rascu A, Otelea M, Mohora M, Muscurel C, et al. Study of fluticasone propionate efficacy in the treatment of patients with bronchial asthma not controlled by other inhaled corticosteroids. Rom. J. Intern. Med. 1998 36 : 105 11.
15. Ozaras R, Tahan V, Turkmen S, Talay F, Besirli K, et al. Changes in malondialdehyde levels in bronchoalveolar fluid and serum by the treatment of asthma with inhaled steroid and beta2-agonist. Respirology 2000 5 : 289 92.
16. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am. Rev. Respir. Dis. 1991 144 : 1202.
17. Jentzsch AM, Bachmann H, Furst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic. Biol. Med. 1996 20 : 251 6.
18. Gleich GJ, Adolphson CR, Kita H. The eosinophil and asthma. In : Busse WW, Holgate ST (eds). Asthma and Rhinitis 1, 2nd edn. Blackwell Science Ltd, Oxford, 2000 429 79.
19. Nadeem A, Chhabra SK, Masood A, Raj HG. Increased oxidative stress and altered levels of antioxidants in asthma. J. Allergy Clin. Immunol. 2003 111 : 72 8.
20. Schmidley JW. Free radicals in central nervous system ischemia. Stroke 1990 21 : 1086 90.
21. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994 343 : 133 5.